Definition and epidemiology
Alcohol use disorder (AUD) is a chronic, relapsing brain disorder defined by an inability to stop or control alcohol use despite adverse social, occupational, or health consequences. The DSM-5 replaced the older categorical terms "alcohol abuse" and "alcohol dependence" with a single spectrum diagnosis of AUD, graded as mild, moderate, or severe based on the number of criteria met.
- Lifetime prevalence in the United States is estimated around 10-15%
- Male-to-female ratio is roughly 2:1, though the gap has been narrowing
- Onset typically occurs in late adolescence to the mid-20s
- Alcohol is one of the leading preventable causes of death worldwide, contributing to liver disease, cardiovascular disease, cancer, trauma, and suicide
Genetic factors account for an estimated 50-60% of the risk, with family history being one of the strongest predictors.
- AST:ALT ratio > 2:1 suggests alcoholic liver disease
- Give thiamine before glucose to avoid precipitating Wernicke encephalopathy
- Delirium tremens peaks 48-96 hours after last drink and is treated with benzodiazepines
- CAGE questionnaire: 2+ positive answers suggest an alcohol problem
- Naltrexone and acamprosate are first-line relapse-prevention medications
- Acamprosate is preferred over naltrexone in significant liver impairment
- Withdrawal seizures typically occur 12-48 hours after cessation
- Disulfiram carries a Black Box Warning: never give during alcohol intoxication or without the patient's knowledge
Etiology and risk factors
AUD arises from an interplay of genetic, neurobiological, psychological, and environmental factors.
Risk factors
- Family history of AUD (first-degree relative)
- Male sex
- Early age of first alcohol use
- Comorbid psychiatric disorders (depression, anxiety, bipolar disorder, antisocial personality disorder)
- Comorbid substance use disorders
- Low socioeconomic status, unemployment, social isolation
- Chronic stress or trauma history, including adverse childhood experiences
- Certain occupations with high availability or social pressure to drink
Protective and modulating factors
Variants in alcohol-metabolizing enzymes (notably ALDH2 deficiency common in East Asian populations) cause a flushing reaction that reduces AUD risk by making drinking unpleasant.
Pathophysiology
Chronic alcohol exposure produces lasting changes in neurotransmission that drive tolerance, dependence, and withdrawal.
- Alcohol acutely potentiates GABA-A receptor activity (sedating, anxiolytic) and inhibits NMDA glutamate receptors (impairing memory, causing blackouts)
- With chronic use, the brain compensates by down-regulating GABA-A receptor sensitivity and up-regulating NMDA receptor density
- When alcohol is abruptly stopped, this adapted state leaves the brain in a hyperexcitable condition: reduced inhibitory (GABA) tone and increased excitatory (glutamate) tone, producing the autonomic hyperactivity, tremor, and seizure risk seen in withdrawal
- The mesolimbic dopamine reward pathway (ventral tegmental area to nucleus accumbens) is activated by alcohol and underlies craving and reinforcement
- Chronic alcohol also causes direct toxic and metabolic effects: hepatic steatosis progressing to steatohepatitis and cirrhosis, pancreatitis, cardiomyopathy, and peripheral neuropathy
- Thiamine (vitamin B1) deficiency, from poor intake and impaired absorption, underlies Wernicke encephalopathy and Korsakoff syndrome
Clinical features
Presentation ranges from early social drinking that has become compulsive to end-stage organ failure.
Behavioral features
- Drinking more or longer than intended
- Unsuccessful attempts to cut down or stop
- Craving or strong urge to drink
- Continued use despite relationship, work, or health problems
- Tolerance (needing more for the same effect) and withdrawal symptoms
Alcohol withdrawal syndrome (timing after last drink)
| Time | Features |
|---|---|
| 6-24 hours | Tremor, anxiety, sweating, nausea, tachycardia, hypertension |
| 12-48 hours | Withdrawal seizures (generalized tonic-clonic) |
| 24-72 hours | Alcoholic hallucinosis (visual/tactile hallucinations, intact orientation) |
| 48-96 hours | Delirium tremens: disorientation, agitation, autonomic instability, hallucinations |
Physical exam clues
- Spider angiomata, palmar erythema, gynecomastia, caput medusae (cirrhosis)
- Hepatomegaly, jaundice
- Peripheral neuropathy, ataxia
- Nystagmus, ophthalmoplegia, confusion, ataxia (Wernicke triad)
Diagnosis
Diagnosis is clinical, based on DSM-5 criteria, supported by screening tools and laboratory findings.
Screening tools
- CAGE questionnaire (Cut down, Annoyed, Guilty, Eye-opener) - two or more positive answers suggest a problem
- AUDIT (Alcohol Use Disorders Identification Test) - more detailed, used in primary care
DSM-5 criteria
At least 2 of 11 criteria within a 12-month period (mild 2-3, moderate 4-5, severe 6+), covering impaired control, social impairment, risky use, and pharmacological criteria (tolerance, withdrawal).
Laboratory findings
- Elevated GGT (sensitive marker of chronic use)
- AST:ALT ratio greater than 2:1 (relatively specific for alcoholic liver disease, unlike viral hepatitis which usually shows ALT > AST)
- Macrocytosis (elevated MCV) without anemia
- Elevated carbohydrate-deficient transferrin (CDT) - more specific but less available
- Thrombocytopenia from direct marrow suppression or splenic sequestration
Blood alcohol concentration confirms recent use but does not establish the diagnosis of AUD.
Differential diagnosis
- Other substance use disorders (sedative-hypnotic, benzodiazepine) - overlapping withdrawal syndromes
- Primary anxiety or mood disorders - may coexist with or be mimicked by alcohol use
- Benzodiazepine withdrawal - similar autonomic and seizure picture, distinguished by history
- Hepatic encephalopathy - altered mentation in a cirrhotic patient without autonomic hyperactivity
- Wernicke encephalopathy - confusion, ataxia, ophthalmoplegia; must be distinguished from and can coexist with intoxication or withdrawal
- Primary seizure disorder - withdrawal seizures are typically generalized and occur in a predictable time window after cessation
- Delirium from other causes (infection, metabolic derangement) - must be excluded in any patient with altered mental status and heavy alcohol use
Management
Management addresses acute withdrawal, underlying AUD, and complications.
Acute withdrawal
- Benzodiazepines (e.g., chlordiazepoxide, lorazepam, diazepam) are first-line for preventing and treating withdrawal seizures and delirium tremens; dosing is symptom-triggered using a validated scale (e.g., CIWA-Ar) in most settings
- Thiamine should be given before or with any glucose administration to prevent precipitating Wernicke encephalopathy
- Supportive care: fluid and electrolyte correction (especially magnesium and potassium), monitoring in a controlled environment for moderate-to-severe withdrawal
Long-term relapse prevention (pharmacotherapy)
- Naltrexone - opioid receptor antagonist, reduces craving and heavy drinking; available oral or long-acting injectable
- Acamprosate - modulates glutamate/GABA balance, helps maintain abstinence; preferred in significant hepatic impairment since it is renally cleared
- Disulfiram - inhibits aldehyde dehydrogenase, causes an aversive reaction (flushing, nausea, tachycardia) with alcohol; requires high motivation and is less favored due to adherence issues. It carries an FDA Black Box Warning: it must never be given to a patient who is currently intoxicated with alcohol, and it must never be administered without the patient's full knowledge, since an unwitting patient who then drinks can develop a severe, potentially life-threatening reaction
- Topiramate and gabapentin are used off-label in some guidelines as alternatives
Psychosocial treatment
- Cognitive behavioral therapy, motivational enhancement therapy
- Mutual-support programs (e.g., Alcoholics Anonymous) as an adjunct
- Family and social support interventions
Guideline consensus (WHO, APA, NICE) agrees that a combination of pharmacotherapy and structured behavioral/psychosocial treatment is more effective than either alone; the choice of specific pharmacotherapy varies by liver function, patient preference, and local availability.
Complications and prognosis
- Hepatic: steatosis, alcoholic hepatitis, cirrhosis, hepatocellular carcinoma
- Gastrointestinal: pancreatitis (acute and chronic), gastritis, esophageal varices, Mallory-Weiss tears
- Neurologic: Wernicke encephalopathy, Korsakoff syndrome, peripheral neuropathy, cerebellar degeneration
- Cardiovascular: dilated cardiomyopathy, atrial fibrillation ("holiday heart"), hypertension
- Psychiatric: depression, anxiety, increased suicide risk
- Social: relationship breakdown, unemployment, legal and financial problems, accidents and trauma
AUD is a chronic relapsing condition; relapse rates are high even after treatment, similar to other chronic diseases like diabetes or hypertension. With sustained treatment engagement, a meaningful proportion of patients achieve long-term abstinence or significantly reduced harmful use. Early intervention and treatment of comorbid psychiatric disease improve outcomes.
CAGE: Cut down, Annoyed, Guilty, Eye-opener - 2+ yes answers suggest an alcohol use problem.
Practice questions
1. A 48-year-old man with a 20-year history of heavy daily alcohol use is brought to the emergency department by his family because he stopped drinking three days ago after running out of money. He is confused, sweating profusely, and reports seeing insects crawling on the walls. Vital signs show heart rate 128/min and blood pressure 170/100 mmHg. Which of the following is the most appropriate immediate treatment?
2. A 55-year-old woman with a long history of alcohol use disorder and cirrhosis wants to start medication to help maintain abstinence after completing detoxification. Which medication is preferred given her significant hepatic impairment?
3. A 42-year-old man with chronic alcohol use is admitted for pneumonia and started on intravenous dextrose for hypoglycemia before any other intervention. Shortly after, he develops confusion, ataxia, and bilateral abducens nerve palsies. Which error in management most likely precipitated this presentation?
Frequently asked questions
What causes alcoholism?
Alcohol use disorder results from a combination of genetic predisposition, altered brain reward and stress circuits, and environmental factors such as early exposure, trauma, and chronic stress. Genetics account for roughly half the risk. Repeated heavy drinking produces lasting changes in GABA and glutamate signaling that drive tolerance, craving, and withdrawal, reinforcing continued use.
What are the first signs of alcohol withdrawal?
The earliest signs are tremor, anxiety, sweating, nausea, and a fast heart rate, usually starting 6 to 24 hours after the last drink. These can progress to withdrawal seizures within 12 to 48 hours, and in severe cases to delirium tremens with confusion and hallucinations by 48 to 96 hours. Anyone with heavy, regular drinking who stops abruptly should be monitored for these symptoms.
How is alcohol use disorder diagnosed?
Diagnosis is clinical, using DSM-5 criteria that assess impaired control, social impairment, risky use, and physical dependence over a 12-month period. Screening tools like CAGE or AUDIT help identify at-risk individuals, and lab tests such as elevated GGT, an AST:ALT ratio above 2:1, and macrocytosis support the diagnosis but do not confirm it alone. A thorough history of drinking patterns and consequences remains central.
Is alcoholism curable?
Alcohol use disorder is treated as a chronic, relapsing condition rather than something that is permanently cured, similar to diabetes or hypertension. With medication, counseling, and ongoing support, many people achieve long-term abstinence or substantial reduction in harmful drinking. Relapse is common and does not mean treatment has failed; it typically prompts adjusting the treatment plan.
Alcohol withdrawal vs delirium tremens - what is the difference?
Alcohol withdrawal is the general syndrome of tremor, anxiety, sweating, and autonomic hyperactivity that begins within hours of stopping drinking. Delirium tremens is the most severe form of withdrawal, occurring in a minority of patients typically 48 to 96 hours after the last drink, marked by disorientation, agitation, hallucinations, and dangerous autonomic instability. Delirium tremens is a medical emergency with a notable mortality risk if untreated.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: F10
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.